My NCBI | Sign In
RSS Settings
  • Search: Thomas Eschenhagen

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 79

    1.

    Atrogin-1 and MuRF1 regulate cardiac MyBP-C levels via different mechanisms.

    Mearini G, Gedicke C, Schlossarek S, Witt CC, Krämer E, Cao P, Gomes MD, Lecker SH, Labeit S, Willis MS, Eschenhagen T, Carrier L.

    Cardiovasc Res. 2009 Nov 18. [Epub ahead of print]PMID: 19850579 [PubMed - as supplied by publisher]Related articles

    2.

    Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction.

    Deuse T, Peter C, Fedak PW, Doyle T, Reichenspurner H, Zimmermann WH, Eschenhagen T, Stein W, Wu JC, Robbins RC, Schrepfer S.

    Circulation. 2009 Sep 15;120(11 Suppl):S247-54.PMID: 19752375 [PubMed - indexed for MEDLINE]Related articles

    3.

    Ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy.

    Carrier L, Schlossarek S, Willis MS, Eschenhagen T.

    Cardiovasc Res. 2009 Aug 10. [Epub ahead of print]PMID: 19617224 [PubMed - as supplied by publisher]Related articles

    4.

    Nonsense-mediated mRNA decay and ubiquitin-proteasome system regulate cardiac myosin-binding protein C mutant levels in cardiomyopathic mice.

    Vignier N, Schlossarek S, Fraysse B, Mearini G, Krämer E, Pointu H, Mougenot N, Guiard J, Reimer R, Hohenberg H, Schwartz K, Vernet M, Eschenhagen T, Carrier L.

    Circ Res. 2009 Jul 31;105(3):239-48. Epub 2009 Jul 9.PMID: 19590044 [PubMed - indexed for MEDLINE]Related articles

    5.

    A new polymorphism in human calmodulin III gene promoter is a potential modifier gene for familial hypertrophic cardiomyopathy.

    Friedrich FW, Bausero P, Sun Y, Treszl A, Krämer E, Juhr D, Richard P, Wegscheider K, Schwartz K, Brito D, Arbustini E, Waldenström A, Isnard R, Komajda M, Eschenhagen T, Carrier L; EUROGENE Heart Failure Project.

    Eur Heart J. 2009 Jul;30(13):1648-55. Epub 2009 May 8.PMID: 19429631 [PubMed - indexed for MEDLINE]Related articles

    6.

    Capturing adenylyl cyclases as potential drug targets.

    Pierre S, Eschenhagen T, Geisslinger G, Scholich K.

    Nat Rev Drug Discov. 2009 Apr;8(4):321-35. Review.PMID: 19337273 [PubMed - indexed for MEDLINE]Related articles

    7.

    Treatment with atorvastatin partially protects the rat heart from harmful catecholamine effects.

    Schmechel A, Grimm M, El-Armouche A, Höppner G, Schwoerer AP, Ehmke H, Eschenhagen T.

    Cardiovasc Res. 2009 Apr 1;82(1):100-6. Epub 2009 Jan 9.PMID: 19136528 [PubMed - indexed for MEDLINE]Related articles

    8.

    Beta-adrenergic stimulation and myocardial function in the failing heart.

    El-Armouche A, Eschenhagen T.

    Heart Fail Rev. 2009 Dec;14(4):225-41.PMID: 19110970 [PubMed - in process]Related articles

    9.

    Mechanical unloading of the rat heart involves marked changes in the protein kinase-phosphatase balance.

    Schwoerer AP, Neuber C, Schmechel A, Melnychenko I, Mearini G, Boknik P, Kirchhefer U, Schmitz W, Ehmke H, Eschenhagen T, El-Armouche A.

    J Mol Cell Cardiol. 2008 Dec;45(6):846-52. Epub 2008 Sep 20.PMID: 18848565 [PubMed - indexed for MEDLINE]Related articles

    10.

    Activation of negative regulators of the hypoxia-inducible factor (HIF) pathway in human end-stage heart failure.

    Zolk O, Solbach TF, Eschenhagen T, Weidemann A, Fromm MF.

    Biochem Biophys Res Commun. 2008 Nov 14;376(2):315-20. Epub 2008 Sep 7.PMID: 18782560 [PubMed - indexed for MEDLINE]Related articles

    11.

    Unloaded rat hearts in vivo express a hypertrophic phenotype of cardiac repolarization.

    Schwoerer AP, Melnychenko I, Goltz D, Hedinger N, Broichhausen I, El-Armouche A, Eschenhagen T, Volk T, Ehmke H.

    J Mol Cell Cardiol. 2008 Nov;45(5):633-41. Epub 2008 Mar 10.PMID: 18721926 [PubMed - indexed for MEDLINE]Related articles

    12.

    Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy.

    El-Armouche A, Wittköpper K, Degenhardt F, Weinberger F, Didié M, Melnychenko I, Grimm M, Peeck M, Zimmermann WH, Unsöld B, Hasenfuss G, Dobrev D, Eschenhagen T.

    Cardiovasc Res. 2008 Dec 1;80(3):396-406. Epub 2008 Aug 8.PMID: 18689792 [PubMed - indexed for MEDLINE]Related articles

    13.

    Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial.

    Düngen HD, Apostolović S, Inkrot S, Tahirović E, Krackhardt F, Pavlović M, Putniković B, Lainscak M, Gelbrich G, Edelmann F, Wachter R, Eschenhagen T, Waagstein F, Follath F, Rauchhaus M, Haverkamp W, Osterziel KJ, Dietz R; CIBIS-ELD Investigators, Subproject Multicenter Trials in the Competence Network Heart Failure.

    Clin Res Cardiol. 2008 Sep;97(9):578-86. Epub 2008 Jun 9.PMID: 18542839 [PubMed - indexed for MEDLINE]Related articles

    14.

    Angiotensin II and myosin light-chain phosphorylation contribute to the stretch-induced slow force response in human atrial myocardium.

    Kockskämper J, Khafaga M, Grimm M, Elgner A, Walther S, Kockskämper A, von Lewinski D, Post H, Grossmann M, Dörge H, Gottlieb PA, Sachs F, Eschenhagen T, Schöndube FA, Pieske B.

    Cardiovasc Res. 2008 Sep 1;79(4):642-51. Epub 2008 May 24.PMID: 18503051 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    The slow force response to stretch in atrial and ventricular myocardium from human heart: functional relevance and subcellular mechanisms.

    Kockskämper J, von Lewinski D, Khafaga M, Elgner A, Grimm M, Eschenhagen T, Gottlieb PA, Sachs F, Pieske B.

    Prog Biophys Mol Biol. 2008 Jun-Jul;97(2-3):250-67. Epub 2008 Mar 14. Review.PMID: 18466959 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Beta-adrenergic signaling in heart failure-adapt or die.

    Eschenhagen T.

    Nat Med. 2008 May;14(5):485-7. No abstract available. PMID: 18463653 [PubMed - indexed for MEDLINE]Related articles

    17.

    ATP-binding cassette transporters in human heart failure.

    Solbach TF, Paulus B, Weyand M, Eschenhagen T, Zolk O, Fromm MF.

    Naunyn Schmiedebergs Arch Pharmacol. 2008 May;377(3):231-43. Epub 2008 Apr 8.PMID: 18392808 [PubMed - indexed for MEDLINE]Related articles

    18.

    Inhibition of aldehyde dehydrogenase type 2 attenuates vasodilatory action of nitroglycerin in human veins.

    Huellner MW, Schrepfer S, Weyand M, Weiner H, Wimplinger I, Eschenhagen T, Rau T.

    FASEB J. 2008 Jul;22(7):2561-8. Epub 2008 Feb 13.PMID: 18272654 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Thyroid hormone regulates developmental titin isoform transitions via the phosphatidylinositol-3-kinase/ AKT pathway.

    Krüger M, Sachse C, Zimmermann WH, Eschenhagen T, Klede S, Linke WA.

    Circ Res. 2008 Feb 29;102(4):439-47. Epub 2007 Dec 20.PMID: 18096819 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Long-term beta-adrenergic stimulation leads to downregulation of protein phosphatase inhibitor-1 in the heart.

    El-Armouche A, Gocht F, Jaeckel E, Wittköpper K, Peeck M, Eschenhagen T.

    Eur J Heart Fail. 2007 Nov;9(11):1077-80. Epub 2007 Oct 24.PMID: 17921049 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    4 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity